Anti Pd-1 And Pd-L1 Antibodies And Immunotherapy

In recent years, anti-PD-1 and PD-L1 antibodies have been postulated as the great promise in the field of cancer immunotherapy . There are more and more clinical trials with monoclonal antibodies against these targets that are being carried out, with results that, far from being the definitive therapy, are encouraging to advance in the treatment … Read more